Barrie Lyell
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 10
- Surgery 2
- Kawasaki Disease and Coronary Complications 1
- Infectious Diseases and Tuberculosis 1
- Co-authors
- Jonathan Neuhoff (1 shared paper)Hariharan Subbiah Ponniah (1 shared paper)Maria Wostrack (1 shared paper)Santhosh G. Thavarajasingam (1 shared paper)Florian Ringel (1 shared paper)Benjamin Marshall Davies (1 shared paper)Hugh McCaughan (1 shared paper)Ann-Kathrin Jörger (1 shared paper)
- Journals
- The Lancet (6 papers)EClinicalMedicine (1 paper)Nature Communications (1 paper)Neurosurgery (1 paper)The Lancet Diabetes & Endocrinology (1 paper)
- Partner nations
- United KingdomGermanyVietnam
In The Last Decade
Barrie Lyell
13 papers receiving 1.6k citations
Barrie Lyell's Hit Papers
Peers
Comparison fields: 5 of 83
- Infectious Diseases 1.3k
- Applied Microbiology and Biotechnology 35
- Internal Medicine 27
- Statistics and Probability 47
- Oncology 77
Countries citing papers authored by Barrie Lyell
This map shows the geographic impact of Barrie Lyell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barrie Lyell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barrie Lyell more than expected).
Fields of papers citing papers by Barrie Lyell
This network shows the impact of papers produced by Barrie Lyell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barrie Lyell. The network helps show where Barrie Lyell may publish in the future.
Co-authors
The 14 scholars most cited alongside Barrie Lyell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 5 | 2021 | 213 | |
| 6 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 7 | 2022 | 26 | |
| 8 | 2023 | 25 | |
| 9 | 2024 | 24 | |
| 10 | 2024 | 7 | |
| 11 | 2024 | 6 | |
| 12 | 2025 | 5 | |
| 13 | 2025 | 2 |
About Barrie Lyell
Barrie Lyell is a scholar working on Infectious Diseases, Surgery, Cardiology and Cardiovascular Medicine, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 13 papers that have together received 1.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (10 papers), Cardiac, Anesthesia and Surgical Outcomes (1 paper), Kawasaki Disease and Coronary Complications (1 paper) and Infectious Diseases and Tuberculosis (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Applied Microbiology and Biotechnology (35 citations), Internal Medicine (27 citations), Statistics and Probability (47 citations) and Oncology (77 citations). Barrie Lyell has collaborated with scholars based in United Kingdom, Germany and Vietnam. Frequent co-authors include Jonathan Neuhoff, Hariharan Subbiah Ponniah, Maria Wostrack, Santhosh G. Thavarajasingam, Florian Ringel, Benjamin Marshall Davies, Hugh McCaughan, Ann-Kathrin Jörger, Bernhard Meyer and Ehab Shiban. Their work appears in journals such as The Lancet, EClinicalMedicine, Nature Communications, Neurosurgery and The Lancet Diabetes & Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.